Wellington Management Group LLP Prometheus Biosciences, Inc. Transaction History

Wellington Management Group LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$103.46 - $126.29 $43,246 - $52,789	-418 Reduced 1.25%	32,976 $3.54 Million
Q4 2022 Feb 13, 2023	BUY	$36.06 - $117.21 $530,226 - $1.72 Million	14,704 Added 78.67%	33,394 $3.67 Million
Q3 2022 Nov 14, 2022	BUY	$28.17 - $59.01 $526,497 - $1.1 Million	18,690 New	18,690 $1.1 Million
Q2 2021 Aug 16, 2021	SELL	$16.8 - $29.65 $2.52 Million - $4.45 Million	-150,193 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$16.51 - $25.29 $2.48 Million - $3.8 Million	150,193 New	150,193 $2.74 Million

29.6K

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.